Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Illuminated Chopper in Cataract Surgery (IChopper)

28 de setembro de 2026 atualizado por: YES Eye Clinic

Prospective Randomized, Paired-Eye, Comparative Study Between Cataract Surgeries With and Without an Illuminated Chopper

This study compares cataract surgery performed with an illuminated chopper and intracameral illumination with cataract surgery performed under conventional external coaxial microscope illumination. Participants undergoing bilateral cataract surgery will have one eye treated with the illuminated chopper and the other eye treated without the illuminated chopper, with the order randomized between eyes.

The study will evaluate differences in operation time, pupil size, the need for additional intraocular medications or devices, intraoperative and postoperative complications, and postoperative clinical outcomes including visual acuity and intraocular pressure.

Visão geral do estudo

Descrição detalhada

This is a prospective, randomized, paired-eye comparative clinical study in participants undergoing bilateral cataract surgery. Each participant will undergo cataract surgery in both eyes. One eye will be treated using the iChopper illumination chopper with the iVision light source, while the fellow eye will undergo cataract surgery using conventional external coaxial microscope illumination. The order of the surgical method between the right and left eyes will be randomized.

The illuminated chopper provides intracameral illumination during cataract surgery and is designed to improve visualization of intraocular structures while also functioning as a lens chopper. The investigational device has received U.S. FDA 510(k) clearance.

The study will assess intraoperative outcomes including operation time, pupil size, ultrasound usage time, pupil-related surgical difficulties, intraoperative complications, and the use of additional intraocular medications or devices. Postoperative assessments will include visual acuity, manifest refraction, intraocular pressure, and postoperative complications.

Participants will undergo bilateral cataract surgery with the two procedures scheduled approximately 1 to 3 weeks apart. Follow-up assessments will be performed approximately 1 day and 30 days after surgery for each eye.

Tipo de estudo

Intervencional

Inscrição (Real)

28

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Florida
      • Cape Coral, Florida, Estados Unidos, 33904
        • Tyson Eye

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

40 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Age 40 years or older
  • Diagnosis of bilateral cataract
  • Both eyes suitable for cataract surgery
  • Expected postoperative best-corrected visual acuity of 0.2 Snellen or better
  • No other secondary ocular surgeries planned during the study period
  • Ability to comply with all study procedures and follow-up visits
  • Ability and willingness to provide written informed consent

Exclusion Criteria:

  • Preoperative ocular or systemic conditions, or medication use, that may affect study outcomes, increase risk to the participant, or predispose to complications, including infectious disease, ocular atrophy, or zonular weakness
  • Poorly controlled diabetes mellitus
  • Use of alpha-blockers such as tamsulosin for benign prostatic hyperplasia
  • Planned femtosecond laser-assisted cataract surgery
  • Congenital ocular disorders
  • History of ophthalmic surgery in either eye that may affect study outcomes or increase risk, including retinal surgery, glaucoma surgery, or anterior segment surgery
  • Inability to provide informed consent
  • Pregnancy

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Illuminated Chopper in Right Eye

Participants assigned to this arm undergo cataract surgery using the illuminated chopper in the right eye and cataract surgery under conventional external coaxial microscope illumination in the left eye.

Cataract surgery is performed using the iChopper illumination chopper with the iVision light source to provide intracameral illumination during phacoemulsification.

Cataract surgery is performed under conventional external coaxial illumination from the surgical microscope without use of the illuminated chopper.

Experimental: Illuminated Chopper in Left Eye

Participants assigned to this arm undergo cataract surgery under conventional external coaxial microscope illumination in the right eye and cataract surgery using the illuminated chopper in the left eye.

Cataract surgery is performed using the iChopper illumination chopper with the iVision light source to provide intracameral illumination during phacoemulsification.

Cataract surgery is performed under conventional external coaxial illumination from the surgical microscope without use of the illuminated chopper.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Operation Time
Prazo: During cataract surgery

Operation time during cataract surgery will be recorded and compared between eyes undergoing surgery with the illuminated chopper and eyes undergoing surgery with conventional microscope illumination.

During cataract surgery
Pupil Size During Cataract Surgery
Prazo: During cataract surgery

Pupil size during cataract surgery will be assessed and compared between the illuminated chopper and conventional microscope illumination conditions.

During cataract surgery
Use of Additional Intraocular Medications
Prazo: During cataract surgery

The use of additional intraocular medications during cataract surgery will be recorded and compared between the illuminated chopper and conventional microscope illumination conditions.

During cataract surgery
Use of Additional Intraocular Devices
Prazo: During cataract surgery

The use of additional intraocular devices during cataract surgery will be recorded and compared between the illuminated chopper and conventional microscope illumination conditions.

During cataract surgery

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Intraoperative Complications
Prazo: During cataract surgery

Intraoperative complications occurring during cataract surgery, including pupil-related and other surgical complications, will be recorded and compared between the two surgical conditions.

During cataract surgery
Postoperative Complications
Prazo: From surgery through approximately 30 days after surgery

Postoperative complications following cataract surgery will be recorded and compared between eyes treated with and without the illuminated chopper.

From surgery through approximately 30 days after surgery
Postoperative Distance Visual Acuity
Prazo: Day 1 and Day 30 after surgery

Distance visual acuity will be assessed after cataract surgery and compared between the illuminated chopper and conventional microscope illumination conditions.

Day 1 and Day 30 after surgery
Postoperative Intraocular Pressure
Prazo: Day 1 and Day 30 after surgery

Intraocular pressure will be assessed during postoperative follow-up and compared between the illuminated chopper and conventional microscope illumination conditions.

Day 1 and Day 30 after surgery

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Incidence of Adverse Events
Prazo: From surgery through approximately 30 days after surgery

The incidence of adverse events following cataract surgery will be assessed, including cystoid macular edema, endophthalmitis, lens luxation, pupillary block, retinal detachment, and persistent elevation of intraocular pressure requiring treatment.

From surgery through approximately 30 days after surgery
Incidence of Postoperative Ocular Complications
Prazo: From surgery through approximately 30 days after surgery

Ocular complications will be assessed, including flat anterior chamber, vitreous in the anterior chamber, residual lens material, intraocular lens decentration or tilt, posterior capsular fibrosis or opacity, and intraocular pressure elevation requiring treatment.

From surgery through approximately 30 days after surgery

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Diretor de estudo: Dong Heun Nam, MD, PhD, Gachon University Gil Medical Center, College of Medicine, Incheon, Republic of Korea

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

14 de setembro de 2023

Conclusão Primária (Real)

7 de março de 2024

Conclusão do estudo (Real)

7 de março de 2024

Datas de inscrição no estudo

Enviado pela primeira vez

19 de setembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

19 de setembro de 2026

Primeira postagem (Real)

25 de setembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

2 de outubro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

28 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • OCL-IIC-01
  • RS-2022-00141533 (Número de outro subsídio/financiamento: The Korean government (the Ministry of Science and ICT; the Ministry of Trade, Industry, and Energy))

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

De-identified individual participant data may be shared with qualified researchers upon reasonable request after publication, subject to review by the study investigators and sponsor and in accordance with applicable ethical, privacy, and regulatory requirements.

Prazo de Compartilhamento de IPD

Beginning after publication of the primary study results and available for 5 years thereafter.

Critérios de acesso de compartilhamento IPD

Data will be made available to qualified researchers who submit a reasonable and scientifically sound request. Requests will be reviewed by the study investigators and sponsor. Access will be provided for approved research purposes, subject to appropriate data use agreements and compliance with applicable ethical, privacy, and regulatory requirements.

Tipo de informação de suporte de compartilhamento de IPD

  • PROTOCOLO DE ESTUDO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Sim

produto fabricado e exportado dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever